
BioXcel Therapeutics BTAI
€ 1.04
-1.61%
Geschäftsbericht 2025
hinzugefügt 27.03.2026
BioXcel Therapeutics P/S 2011-2026 | BTAI
P/S Jährlich BioXcel Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 2.37 | 3.71 | 210 | - | 41.3 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.3 M | 2.37 | 8.27 M |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Exelixis
EXEL
|
5.05 | $ 48.16 | 4.22 % | $ 13.1 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 94.13 | 1.19 % | $ 22.8 B | ||
|
Fortress Biotech
FBIO
|
1.23 | $ 2.39 | -0.42 % | $ 66.7 M | ||
|
Forte Biosciences
FBRX
|
181 | $ 24.02 | -8.22 % | $ 311 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.9 | 1.4 % | $ 271 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.4 | -0.71 % | $ 3.71 B | ||
|
Genmab A/S
GMAB
|
15.6 | $ 26.43 | -2.33 % | $ 1.71 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.14 | - | $ 653 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.51 | -0.85 % | $ 5.78 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Gilead Sciences
GILD
|
6.23 | $ 131.33 | -2.04 % | $ 163 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 21.17 | 2.47 % | $ 2.69 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Grifols, S.A.
GRFS
|
0.627 | $ 8.1 | 0.5 % | $ 5.51 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.25 K | $ 54.83 | 4.6 % | $ 4.93 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.57 | -2.48 % | $ 418 M |